SCHEMBL6184593

SCHEMBL6184593

COc1ccccc1OCC(O)CN1C[CH]N(c2nc3cc(Cl)ccc3o2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 4/20 0.46
MEN1 O00255 6/20 0.45
KMT2A Q03164 6/20 0.45
USP2 O75604 2/20 0.45
HTT P42858 1/20 0.45
MAPT P10636 6/20 0.44
HSF1 Q00613 1/20 0.43
LMNA P02545 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 3/20 0.42
TSHR P16473 3/20 0.41
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
ADRB1 P08588 2/20 0.41
ADRA2A P08913 2/20 0.41
ADRA2B P18089 2/20 0.41
ADRA2C P18825 2/20 0.41
ADRA1A P35348 2/20 0.41
DRD3 P35462 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5222885 0.86 MEN1 (0.49) HRH1MEN1KMT2AUSP2HTT
SCHEMBL4866518 0.78 KCNH2 (0.59) HRH1MAPTHSF1LMNANPSR1
SCHEMBL5224373 0.74 IDO1 (0.48) HRH1MEN1KMT2AUSP2HTT
SCHEMBL5223033 0.73 MEN1 (0.47) HRH1MEN1KMT2AUSP2HTT
SCHEMBL2332160 0.72 LMNA (0.73) HRH1MEN1KMT2AUSP2HTT
SCHEMBL6207329 0.72 KCNH2 (0.49) HRH1MEN1KMT2AUSP2HTT
SCHEMBL7007007 0.68 CYP3A4 (0.44) MEN1KMT2AUSP2MAPTLMNA
SCHEMBL23057178 0.68 LMNA (0.66) HRH1MEN1KMT2AUSP2HTT
SCHEMBL31510205 0.68 LMNA (0.66) HRH1MEN1KMT2AUSP2HTT
SCHEMBL15296749 0.67 ADRB2 (0.73) MEN1KMT2AHTTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567525-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2005-08-31 EP disclosed
WO-2004052887-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2004-06-24 WO disclosed